Home
News
Create
Screeners
Insights
Aarti Pharma Labs
776.
80
-6.55
(-0.84%)
Market Cap
₹7,041.48 Cr
PE Ratio
29.62
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.84%
1M
+6.32%
6M
-10.65%
1Y
+22.08%
5Y
+169.49%
View Company Insights
Latest news about Aarti Pharma Labs
Aarti Pharmalabs Limited Receives Rs 2.60 Lakh Penalty from CGST Authority
3 hrs ago
Today
Aarti Pharmalabs Limited has received a Rs 2.60 lakh penalty from CGST and Central Excise authority under Section 74 of CGST Act, 2017. The penalty is part of a larger demand of Rs 31,15,608 related to alleged excess Input Tax Credit availment and incorrect tax liability declarations for FY2022-23 and FY2023-24. The company states no material impact on financials or operations is expected.
Aarti Pharmalabs Limited Schedules Q3FY26 Earnings Conference Call for February 10, 2026
4 days ago
Aarti Pharmalabs Limited Appoints Dr. Rakeshwar Bandichhor as Chief Scientific Officer - R&D
Jan 01, 2026
Aarti Pharmalabs Reports 11% Revenue Growth in Q2FY26, Revises EBITDA Growth Guidance
Nov 17, 2025
Aarti Pharmalabs Reports Strong Q2 Performance with 11% Revenue Growth
Nov 09, 2025
More news about Aarti Pharma Labs
09
Nov 25
Aarti Pharma Labs Bolsters Leadership with Two Key Senior Management Appointments
Aarti Pharma Labs Limited has announced two significant appointments to its senior management team, effective November 10, 2025. Mr. Hemant Gundare, with a doctorate in Green Chemistry, joins as Head Corporate - EHS (Environment, Health & Safety). Mr. Shrihari S. Mane, with 32 years of experience in API manufacturing, has been appointed as Chief Technology Officer (API). These appointments, approved by the Board of Directors on November 9, 2025, aim to enhance the company's environmental sustainability, safety practices, and technological capabilities in API manufacturing.
Aarti Pharma Labs
776.
80
-
6.
55
(-
0.
84
%)
1 Year Returns:
+22.08%
Industry Peers
Sun Pharmaceutical
1,695.10
(-
0.
44
%)
Divis Laboratories
6,024.50
(-
1.
91
%)
Torrent Pharmaceuticals
3,939.00
(-
0.
94
%)
Cipla
1,330.00
(-
0.
25
%)
Dr Reddys Laboratories
1,241.20
(-
0.
30
%)
Lupin
2,173.70
(-
2.
02
%)
Zydus Life Science
888.15
(-
1.
86
%)
Mankind Pharma
2,060.20
(-
0.
97
%)
Aurobindo Pharma
1,191.00
(+
0.
80
%)
Alkem Laboratories
5,684.00
(+
0.
38
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation